This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Nanjing Delova Biotech Co., Ltd., Shanghai Institute of Pharmaceutical Industry. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2024
Title: Innovations of Inventor Wenliang Zhou
Introduction
Wenliang Zhou is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compositions and methods. With a total of two patents to his name, Zhou's work focuses on enhancing the solubility and stability of pharmaceutical compounds.
Latest Patents
Wenliang Zhou's latest patents include a meloxicam composition and a pharmaceutical preparation method. The first patent relates to meloxicam compositions that contain meloxicam and cosolvents, which are mixed solvents including water and organic solvents. This invention significantly enhances the solubility of meloxicam in liquid pharmaceutical preparations, making it suitable for intravenous injection to achieve effective therapeutic concentrations for post-operative analgesia. The second patent involves crystals of prasugrel hydrobromate, which possess excellent stability and solubility. This patent discloses crystal compositions and their pharmaceutical applications.
Career Highlights
Throughout his career, Wenliang Zhou has worked with reputable organizations such as Nanjing Delova Biotech Co., Ltd. and the Shanghai Institute of Pharmaceutical Industry. His experience in these institutions has contributed to his expertise in pharmaceutical innovations.
Collaborations
Wenliang Zhou has collaborated with notable coworkers, including Qingsong Wang and Qu Wu. Their combined efforts have further advanced the research and development of pharmaceutical compositions.
Conclusion
Wenliang Zhou's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving drug formulations. His work continues to impact the field positively, enhancing the effectiveness of treatments available today.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile